NeuroOne Medical Technologies Corporation (NMTC) Capital expenditures 2019–2025
NeuroOne Medical Technologies Corporation (NMTC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$81,742FY2025 · since FY2019: $58,352 → $81,742
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $81,742 | -32.0% |
| FY2024 | $120,197 | -68.7% |
| FY2023 | $384,117 | +39.6% |
| FY2022 | $275,226 | +310.3% |
| FY2021 | $67,079 | -45.2% |
| FY2020 | $122,427 | +109.8% |
| FY2019 | $58,352 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice